Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study
暂无分享,去创建一个
David P. Smith | J. Emery | E. Banks | K. Canfell | D. O’Connell | V. Nair-Shalliker | A. Bang | D. Goldsbury | M. Weber | M. Caruana
[1] David P. Smith,et al. Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study , 2018, Scientific Reports.
[2] T. Littlejohns,et al. Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research , 2016, Cancer epidemiology.
[3] Carolyn M. Brown,et al. Predictors of prostate cancer screening using Andersen's Behavioral Model of Health Services Use. , 2016, Urologic oncology.
[4] M. Hoshen,et al. Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men , 2016, Diabetologia.
[5] S. Wild,et al. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals , 2016, Diabetologia.
[6] C. Qin,et al. Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies , 2016, International Urology and Nephrology.
[7] S. Eggener,et al. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[9] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[10] N. Lawrentschuk,et al. Prostate cancer screening in Primary Health Care: the current state of affairs , 2015, SpringerPlus.
[11] B. Armstrong,et al. Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer , 2014 .
[12] K. Bennett,et al. Prostate specific antigen testing is associated with men’s psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study , 2014, BMC Family Practice.
[13] T. Churches,et al. Quantifying under-reporting of pathology tests in Medical Benefits Schedule claims data. , 2013, Australian health review : a publication of the Australian Hospital Association.
[14] M. Harris,et al. Validating self-report of diabetes use by participants in the 45 and up study: a record linkage study , 2013, BMC Health Services Research.
[15] David P. Smith,et al. Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study , 2013, BMC Public Health.
[16] Ashwin A. Kotwal,et al. The Influence of Stress, Depression, and Anxiety on PSA Screening Rates in a Nationally Representative Sample , 2012, Medical care.
[17] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[18] S. Chambers,et al. Patterns of prostate‐specific antigen (PSA) testing in Australian men: the influence of family history , 2012, BJU international.
[19] Guixiang Zhao,et al. Use of the Prostate-Specific Antigen Test Among Men Aged 75 Years or Older in the United States: 2006 Behavioral Risk Factor Surveillance System , 2010, Preventing chronic disease.
[20] A. Bauman,et al. Screen-time, obesity, ageing and disability: findings from 91 266 participants in the 45 and Up Study , 2010, Public Health Nutrition.
[21] David G Steel,et al. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs , 2010, BMC medical research methodology.
[22] G. Giles,et al. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake. , 2007, Urology.
[23] V. Beral,et al. Cohort Profile: The 45 and Up Study , 2007, International journal of epidemiology.
[24] P. Cornford,et al. PSA testing: are patients aware of what lies ahead? , 2006, Annals of the Royal College of Surgeons of England.
[25] S. Vernon,et al. Factors influencing behavioral intention regarding prostate cancer screening among older African-American men. , 2006, Journal of the National Medical Association.
[26] R. Cumming,et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men , 2005, The Lancet.
[27] A. Jemal,et al. Global Cancer Statistics , 2011 .
[28] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.